Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plague Vaccine”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Testing effectiveness (Phase 2)Study completedNCT00332956
What this trial is testing

Title: Recombinant Plague Vaccine rF1V in Healthy Volunteers

Who this might be right for
Healthy Volunteers
DynPort Vaccine Company LLC, A GDIT Company 400
Early research (Phase 1)Study completedNCT00097396
What this trial is testing

Safety, Tolerability & Immunogenicity of the Recombinant Plague Vaccine rF1V

Who this might be right for
Pneumonic PlaguePreventive Therapy
DynPort Vaccine Company LLC, A GDIT Company 40
Testing effectiveness (Phase 2)UnknownNCT05330624
What this trial is testing

Immunogenicity and Safety of Subunit Vaccine of Plague Vaccine With Two Immunization Regimens

Who this might be right for
Plague
Jiangsu Province Centers for Disease Control and Prevention 720
Testing effectiveness (Phase 2)Study completedNCT02596308
What this trial is testing

Immunogenicity and Safety of Subunit Plague Vaccine

Who this might be right for
Plague
Jiangsu Province Centers for Disease Control and Prevention 240
Testing effectiveness (Phase 2)Study completedNCT05506969
What this trial is testing

Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of Age

Who this might be right for
Plague, PneumonicPlagueVaccine-Preventable Diseases
Dynavax Technologies Corporation 200
Early research (Phase 1)Study completedNCT01381744
What this trial is testing

Dose Escalation Trial of a Plague Vaccine, Flagellin/F1/V, in Healthy Adult Volunteers

Who this might be right for
Plague
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Study completedNCT01122784
What this trial is testing

Randomized Single-Blinded Study to Evaluate Safety and Immunogenicity of Recombinant Plague Vaccine With and Without Adjuvant

Who this might be right for
Plague Vaccine
DynPort Vaccine Company LLC, A GDIT Company 402
Testing effectiveness (Phase 2)Looking for participantsNCT07207408
What this trial is testing

Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age

Who this might be right for
Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersenia Pestis
Dynavax Technologies Corporation 148
Early research (Phase 1)Study completedNCT00246467
What this trial is testing

One Year Study to Evaluate Three Different Adjuvanted Doses of the Recombinant Plague Vaccine (rF1 and rV Antigens)

Who this might be right for
Plague
PharmAthene UK Limited 123